Numera’s Herd Immunity Tracker: A break-through month

June 4, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, June 4, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Since early May, improvements in vaccine distribution have significantly cut back projected times towards herd immunity. In only four weeks, daily inoculation rates have doubled to 0.6% of the global population, reducing the timeline towards 70%+ immunity by 5M.

Much of this progress stems from emerging markets, led by an extremely rapid rollout in China. In developed markets, accelerating vaccinations in Europe and Canada offset a weakening take-up rate in the US.

Read More

Hedging inflation risk

June 3, 2021 | Articles

The May 2021 edition of Numera’s US Macro Monitor explores the factors behind high US inflation, and discusses various strategies to minimize inflationary risk. While an inflationary spiral remains unlikely, we expect higher trend inflation than in the past 5Y, weakening the relative appeal of 60/40 portfolios.

Read More

Temporary slowdown in industrial activity

June 3, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, June 3, 2021 (Press Release) – Numera today released the latest update of its Global Industrial Tracker, which points to growth slowing into the second quarter.

After rising roughly 1% per month in Q1/21, global production rose an estimated 0.3% month-over-month in April – in line with its long-term trend. Looked at by region, most of the growth is now stemming from advanced economies, where improved business and consumer sentiment are boosting the production of investment and consumer goods.

Read More

Global manufacturing growth continued in Q2

May 31, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, May 31, 2021 (Press Release) – Numera today released the latest update of its Global Manufacturing Tracker, which reveals manufacturing output continued to expand into the second quarter.  Read More

Numera’s Herd Immunity Tracker: Six months to normality

May 28, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, May 28, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Global vaccination rates accelerated further this past week, cutting back the estimated time towards 70%+ immunity by 11% to six months. Despite falling US vaccinations, developed markets as a whole maintained a steady pace of inoculations, owing to strong demand for initial doses in Europe and Canada.

In EMs, a rapid vaccine rollout in China allowed EMs to reduce the projected time towards 70% immunity by four weeks to 7 months. The EM aggregate remains weighed down by India, where production backlogs have resulted in a near 50% decline in the daily pace of vaccinations over the past month.

Read More

Low mobility weighing on returns

May 27, 2021 | Articles

In the May 2021 edition of Numera’s Global Macro Monitor, we investigate the EM equity implications of vaccine inequality. Although global ‘reflation’ benefits EM assets, stark differences in public health risks versus DMs weakens the relative appeal of EM stocks versus past reflationary episodes.

Read More

Retail spending recovered from second wave

May 26, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, May 26, 2021 (Press Release) – Numera today released the latest update of its Global Retail Sales Tracker, which suggests that global retail spending recovered from its second wave lull.

Global retail spending likely grew 1.2% MoM in April (+30% YoY), fueled by rising mobility and improving consumer confidence across developed markets (DMs). DM retail sales are now 4.5% higher than their pre-crisis level.

Read More

Numera’s Herd Immunity Tracker: Developed market health risks easing

May 21, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, May 21, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Global vaccination campaigns continue to accelerate, with daily vaccinations increasing by 1.4M people per day over this past week to 0.45% of the world population. As a result, the estimated time towards 70%+ immunity is down 10% during this period to 7.3 months (end of December).

In developed markets (DMs), most of the improvement stems from the Eurozone and Canada, which over the past two weeks have vaccinated a staggering 1% of their population per day. Public health risks have eased considerably, with daily per capita case counts across DMs down 50% over the past month and 75% YTD.

Read More

EZ economy shows signs of recovery

May 18, 2021 | Articles

The May 2021 edition of Numera Analytics’ Global Macro Perspectives report features in-depth commentary of the key macro themes shaping the global economic outlook, as well as our latest country and regional views on growth, inflation, and exchange rates. 

Read More

Numera’s Herd Immunity Tracker: The Eurozone awakens

May 14, 2021 | Press

FOR IMMEDIATE RELEASE

MONTREAL, QC, May 14, 2021 (Press Release) – Numera today released the latest update of its Herd Immunity Tracker. This report will be published weekly for the remainder of the year. Its purpose is to complement available information on COVID-19 vaccination rates with timely estimates on projected times remaining until 70%+ immunity for all major economies.

Global vaccination rates picked up last week after stalling in early May, reducing the projected time towards ‘herd’ (70%+) immunity by 9.1% to less than 9 months. In developed markets, most of the improvement stemmed from the Eurozone. Improvements in production and distribution have allowed EZ countries to double daily inoculations over the past month to 1% of the population.

Emerging markets also gained considerable ground, led a rapidly expanding vaccine coverage in China. At the current pace, public health authorities are on track to achieving their stated objective of inoculating 40% of the population by the end of June.

Read More